The R&D activities at Genomic Vision covers a wide and diverse range of scientific activities that include molecular biology, surface chemistry, genomics, bioinformatics, biophysics, image analysis and monitoring pharmacogenomic clinical trials.
Genomic Vision’s R&D team focuses on cancer, DNA polymorphisms, pharmacogenomics and inherited and rare diseases that are underpinned by large-scale DNA rearrangements
Find out more about our R&D pipeline: